Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30.8Revenue $M76.9Net Margin (%)57.0Altman Z-Score-2.1
Enterprise Value $M-17.9EPS $0.5Operating Margin %35.0Piotroski F-Score5
P/E(ttm)1.0Beneish M-Score6.0Pre-tax Margin (%)57.0Higher ROA y-yY
Price/Book0.810-y EBITDA Growth Rate %--Quick Ratio4.9Cash flow > EarningsN
Price/Sales0.45-y EBITDA Growth Rate %--Current Ratio4.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)63.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with THLD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THLDFirst Eagle Investment 2015-12-31 Sold Out -0.01%$0.46 - $4.4
($2.95)
$ 0.44-85%Sold Out0
THLDFirst Eagle Investment 2015-09-30 Reduce-0.01%$3.62 - $5.11
($4.31)
$ 0.44-90%Reduce -60.65%500,000
THLDFirst Eagle Investment 2015-06-30 Reduce$3.49 - $4.51
($4.01)
$ 0.44-89%Reduce -9.60%1,270,768
THLDFirst Eagle Investment 2015-03-31 Add$3.33 - $4.61
($3.99)
$ 0.44-89%Add 2.06%1,405,768
THLDFirst Eagle Investment 2014-12-31 Add$2.7 - $3.56
($3.02)
$ 0.44-85%Add 26.17%1,377,448
THLDFirst Eagle Investment 2014-09-30 Add$3.75 - $5.03
($4.2)
$ 0.44-90%Add 36.46%1,091,700
THLDFirst Eagle Investment 2014-03-31 Add0.01%$4.34 - $5.72
($4.92)
$ 0.44-91%Add 250.00%700,000
THLDFirst Eagle Investment 2012-12-31 Buy $3.98 - $6.55
($4.67)
$ 0.44-91%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THLD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THLD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fernandes Joel ASenior Vice President 2015-09-28Buy3,562$3.96-89.14view
JAEGER WILFRED EDirector 2015-02-18Buy25,000$3.75-88.53view
Davar NipunVice President 2014-10-13Buy3,000$2.99-85.62view
YOUNGER WILLIAM H JR10% Owner 2014-10-01Sell242,396$3.77-88.59view
WHITE JAMES N10% Owner 2014-10-01Sell239,538$3.77-88.59view
SWEET DAVID E10% Owner 2014-10-01Sell229,154$3.77-88.59view
Speiser Michael L10% Owner 2014-10-01Sell227,228$3.77-88.59view
SHEEHAN ANDREW T10% Owner 2014-10-01Sell230,352$3.77-88.59view
Pullara Samuel J III10% Owner 2014-10-01Sell226,657$3.77-88.59view
GAITHER JAMES C10% Owner 2014-10-01Sell231,287$3.77-88.59view

Press Releases about THLD :

Quarterly/Annual Reports about THLD:

News about THLD:

Articles On GuruFocus.com
Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL May 12 2015 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 47,619 Shares Mar 15 2011 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 52,356 Shares Oct 06 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 20,000 Shares Jun 05 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
ETF’s with exposure to Threshold Pharmaceuticals, Inc. : April 29, 2016 Apr 29 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 22 2016
ETF’s with exposure to Threshold Pharmaceuticals, Inc. : March 28, 2016 Mar 28 2016
Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer Mar 21 2016
Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer Mar 21 2016
Threshold (THLD): Evofosfamide May Be Effective in Some Pancreatic Cancer Patients Mar 18 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Mar 17 2016
ETF’s with exposure to Threshold Pharmaceuticals, Inc. : March 17, 2016 Mar 17 2016
THRESHOLD PHARMACEUTICALS INC Financials Mar 16 2016
Threshold Pharmaceuticals, Inc. :THLD-US: Earnings Analysis: 2015 By the Numbers Mar 16 2016
Biotech Trade Report Mar 14 2016
Top Penny Stocks to Watch, Friday 3/11/2016 Mar 11 2016
Threshold Pharmaceuticals posts 4Q profit Mar 10 2016
Threshold Pharmaceuticals posts 4Q profit Mar 10 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 10 2016
Threshold Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Year-End 2015... Mar 10 2016
Threshold Pharmaceuticals Announces Presentation and Webcast at the Cowen and Company 36th Annual... Mar 01 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Feb 12 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jan 22 2016
Threshold Pharmaceuticals and Merck KGaA, Darmstadt, Germany Agree to Key Terms for the Licensing... Jan 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)